Sharma BK; Mureb D; Murab S; Rosenfeldt L; Francisco B; Cantrell R; Karns R; Romick-Rosendale L; Watanabe-Chailland M; Mast J. Fibrinogen activates focal adhesion kinase (FAK) promoting colorectal adenocarcinoma growth. Journal of Thrombosis and Haemostasis. 2021; 19(10):2480-2494.

Quinn CT; Niss O; Dong M; Pfeiffer A; Korpik J; Reynaud M; Bonar H; Kalfa TA; Smart LR; Malik P. Early initiation of hydroxyurea (hydroxycarbamide) using individualised, pharmacokinetics-guided dosing can produce sustained and nearly pancellular expression of fetal haemoglobin in children with sickle cell anaemia. British Journal of Haematology. 2021; 194(3):617-625.

Forsyth S; Schroeder P; Geib J; Vrishabhendra L; Konstantinidis DG; LaSalvia K; Ribadeneira MD; Wu E; Kelly P; Kalfa TA. Safety, Pharmacokinetics, and Pharmacodynamics of Etavopivat (FT-4202), an Allosteric Activator of Pyruvate Kinase-R, in Healthy Adults: A Randomized, Placebo-Controlled, Double-Blind, First-in-Human Phase 1 Trial. Clinical Pharmacology in Drug Development. 2022; 11(5):654-665.

Berntorp E; LeBeau P; Ragni MV; Borhany M; Abajas YL; Tarantino MD; Holstein K; Croteau SE; Liesner R; Tarango C. Quality of life in a large multinational haemophilia B cohort (The B-Natural study) - Unmet needs remain. Haemophilia. 2022; 28(3):453-461.

Shook LM; Farrell CB; Mosley C. Expanding a Regional Sickle Cell Disease Project ECHO® to Rapidly Disseminate COVID-19 Education. Advances in Medical Education and Practice. 2022; 13:443-447.